Theranos Investors

A federal judge on Thursday <strong><a href="http://www.courthousenews.com/wp-content/uploads/2018/06/Theranos-class-cert-DENIED.pdf">declined</a></strong> to certify a class of Theranos investors who claim they were misled by promises of a breakthrough in blood testing, finding their claims need to be <a href="https://www.courthousenews.com/theranos-disputes-class-investments-securities-action/">handled</a> individually rather than as a class action.

SAN JOSE, Calif. – A federal judge on Thursday declined to certify a class of Theranos investors who claim they were misled by promises of a breakthrough in blood testing, finding their claims need to be handled individually rather than as a class action.

Categories / Financial, Science

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.